<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37000988</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Causes of death among United States decedents with ALS: An eye toward delaying mortality.</ArticleTitle><Pagination><StartPage>757</StartPage><EndPage>764</EndPage><MedlinePgn>757-764</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51762</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To report multiple cause of death (MCOD) occurrence among patients in the United States with amyotrophic lateral sclerosis (ALS).</AbstractText><AbstractText Label="METHODS">Using death certificate data for all ALS deaths from 50&#x2009;U.S. states and the District of Columbia, 2011-2014, we tabulated MCOD, used association rules mining (ARM) to determine if MCOD occurred together, and calculated standardized mortality odds ratios (SMOR) for select causes, comparing ALS with other U.S. decedents.</AbstractText><AbstractText Label="RESULTS">Among 24,328 death certificates, there were 25,704 MCOD, excluding ALS. ALS was listed as the sole cause of death in n&#xa0;=&#xa0;11,263 (46%). The most frequent causes of death co-occurring with ALS were respiratory failure (n&#xa0;=&#xa0;6503; 25.3%), cardiovascular disease (n&#xa0;=&#xa0;6077; 12.6%), pneumonia (n&#xa0;=&#xa0;1345; 5.2%), and pneumonitis (n&#xa0;=&#xa0;856; 3.3%). The SMORs among ALS decedents compared with non-ALS decedents for falls and accidents were 3.4 (95% CI 2.6, 4.3) and 3.0 (95% CI 2.2, 4.2), respectively. From ARM analysis, falls and accidents were both associated with injuries. The most common causes identified were weakly to very strongly associated with being an ALS decedent compared with other U.S. deaths, with SMOR point estimates ranging from 1.3 to 51.1.</AbstractText><AbstractText Label="INTERPRETATION">This study provides information about the natural history of ALS. With knowledge that some causes of death may be preventable, healthcare providers may be able to optimize patient care and possibly postpone mortality and reduce morbidity. Moreover, this study located gaps in data; medical certifiers completing death certificates for ALS decedents should ensure all MCOD data are recorded.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Larson</LastName><ForeName>Theodore C</ForeName><Initials>TC</Initials><Identifier Source="ORCID">0000-0003-4719-4829</Identifier><AffiliationInfo><Affiliation>Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goutman</LastName><ForeName>Stephen A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0001-8780-6637</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Bryn</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>Frank J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Office of Community Health Hazard Assessment, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thakur</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>ALS Association, Washington, District of Columbia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry/Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015984" MajorTopicYN="N">Causality</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>31</Day><Hour>15</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37000988</ArticleId><ArticleId IdType="pmc">PMC10187717</ArticleId><ArticleId IdType="doi">10.1002/acn3.51762</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goutman SA, Hardiman O, Al&#x2010;Chalabi A, et&#xa0;al. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21(5):480&#x2010;493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9513753</ArticleId><ArticleId IdType="pubmed">35334233</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman SA, Hardiman O, Al&#x2010;Chalabi A, et&#xa0;al. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21(5):465&#x2010;479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9513754</ArticleId><ArticleId IdType="pubmed">35334234</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai CP, Chang BH, Lee CT. Underlying cause and place of death among patients with amyotrophic lateral sclerosis in Taiwan: a population&#x2010;based study, 2003&#x2010;2008. J Epidemiol. 2013;23(6):424&#x2010;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3834279</ArticleId><ArticleId IdType="pubmed">23933623</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention
. Underlying cause of death 1999&#x2010;2020. 2022.  Accessed January 21, 2022. https://wonder.cdc.gov/wonder/help/ucd.html
</Citation></Reference><Reference><Citation>
Centers for Disease Control and Prevention
. Instructions for completing the cause&#x2010;of&#x2010;death section of the death certificate. 2004; https://www.cdc.gov/nchs/data/dvs/blue_form.pdf
</Citation></Reference><Reference><Citation>Goutman SA, Nowacek DG, Burke JF, Kerber KA, Skolarus LE, Callaghan BC. Minorities, men, and unmarried amyotrophic lateral sclerosis patients are more likely to die in an acute care facility. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(5&#x2013;6):440&#x2010;443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4681497</ArticleId><ArticleId IdType="pubmed">24920400</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro R, Lo Re M, Piccoli T, Piccoli F, La Bella V. Causes and place of death in Italian patients with amyotrophic lateral sclerosis. Acta Neurol Scand. 2010;122(3):217&#x2010;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">20078446</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf J, Safer A, Wohrle JC, et&#xa0;al. Causes of death in amyotrophic lateral sclerosis: results from the Rhineland&#x2010;Palatinate ALS registry. Nervenarzt. 2017;88(8):911&#x2010;918.</Citation><ArticleIdList><ArticleId IdType="pubmed">28184974</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Pradat PF, Salachas F, et&#xa0;al. Causes of death in a post&#x2010;mortem series of ALS patients. Amyotroph Lateral Scler. 2008;9(1):59&#x2010;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">17924236</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R, Huang R, Chen D, et&#xa0;al. Causes and places of death of patients with amyotrophic lateral sclerosis in south&#x2010;West China. Amyotroph Lateral Scler. 2011;12(3):206&#x2010;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">21506897</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson TC, Kaye W, Mehta P, Horton DK. Amyotrophic lateral sclerosis mortality in the United States, 2011&#x2010;2014. Neuroepidemiology. 2018;51(1&#x2013;2):96&#x2010;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6159829</ArticleId><ArticleId IdType="pubmed">29990963</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention
. Instruction manual, Part 9: ICD&#x2010;10 cause&#x2010;of&#x2010;death lists for tabulating mortality statistics. 2011; https://www.cdc.gov/nchs/data/dvs/Part9InstructionManual2011.pdf
</Citation></Reference><Reference><Citation>Naulaerts S, Meysman P, Bittremieux W, et&#xa0;al. A primer to frequent itemset mining for bioinformatics. Brief Bioinform. 2015;16(2):216&#x2010;231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4364064</ArticleId><ArticleId IdType="pubmed">24162173</ArticleId></ArticleIdList></Reference><Reference><Citation>Birjandi SM, Khasteh SH. A survey on data mining techniques used in medicine. J Diabetes Metab Disord. 2021;20(2):2055&#x2010;2071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8630112</ArticleId><ArticleId IdType="pubmed">34900841</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahsler M, Chelluboina S, Hornik K, Buchta C. The arules R&#x2010;package ecosystem: analyzing interesting patterns from large transaction datasets. J Mach Learn Res. 2011;2011(12):2021&#x2010;2025.</Citation></Reference><Reference><Citation>R Core Team . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2018.</Citation></Reference><Reference><Citation>Smith KR, Kliewer EV. Estimating standardized mortality odds ratios with national mortality followback data. Epidemiology. 1995;6(1):55&#x2010;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">7888446</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman DM, Curtis RE, Daugherty SE, Goedert JJ, Kuncl RW, Tucker MA. The association between cancer and amyotrophic lateral sclerosis. Cancer Causes Control. 2013;24(1):55&#x2010;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3529829</ArticleId><ArticleId IdType="pubmed">23090035</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention
. CDC WONDER: Wide&#x2010;ranging online data for epidemiologic research. 2022; https://wonder.cdc.gov/
</Citation></Reference><Reference><Citation>The SAS Institue Inc . SAS Software, Version 9.4. 2012.</Citation></Reference><Reference><Citation>Mehal JM, Holman RC, Schonberger LB, Sejvar JJ. Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999&#x2010;2009. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(5&#x2013;6):346&#x2010;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">23621426</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Raymond J, Punjani R, et&#xa0;al. Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017. Amyotroph Lateral Scler Frontotemporal Degener. 2022;15:1&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9568617</ArticleId><ArticleId IdType="pubmed">35422180</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Raymond J, Punjani R, et&#xa0;al. Incidence of amyotrophic lateral sclerosis in the United States, 2014&#x2010;2016. Amyotroph Lateral Scler Frontotemporal Degener. 2022;13:1&#x2010;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">35023792</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt C, Neuwirth C, Sommacal A, Andersen PM, Weber M. Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post&#x2010;mortem study of 80 ALS patients. PLoS One. 2017;12(5):e0177555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5441602</ArticleId><ArticleId IdType="pubmed">28542233</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar JJ, Holman RC, Bresee JS, Kochanek KD, Schonberger LB. Amyotrophic lateral sclerosis mortality in the United States, 1979&#x2010;2001. Neuroepidemiology. 2005;25(3):144&#x2010;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">15990445</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagami M, Kimura F, Nakajima H, et&#xa0;al. Tracheostomy and invasive ventilation in Japanese ALS patients: decision&#x2010;making and survival analysis: 1990&#x2010;2010. J Neurol Sci. 2014;344(1&#x2013;2):158&#x2010;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">25017882</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorrie GH, Chandran S, Colville S, et&#xa0;al. Improved survival and 30&#x2010;day mortality after gastrostomy in Scottish motor neurone disease patients: evidence from a national retrospective cohort study using STROBE criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(3&#x2013;4):165&#x2010;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">30835562</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Brooks BR, Swain&#x2010;Eng RJ, et&#xa0;al. Quality improvement in neurology: amyotrophic lateral sclerosis quality measures: report of the quality measurement and reporting subcommittee of the American Academy of Neurology. Neurology. 2013;81(24):2136&#x2010;2140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3863352</ArticleId><ArticleId IdType="pubmed">24271651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward AL, Sanjak M, Duffy K, et&#xa0;al. Power wheelchair prescription, utilization, satisfaction, and cost for patients with amyotrophic lateral sclerosis: preliminary data for evidence&#x2010;based guidelines. Arch Phys Med Rehabil. 2010;91(2):268&#x2010;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">20159132</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F, Valdimarsdottir U, Furst CJ, et&#xa0;al. Suicide among patients with amyotrophic lateral sclerosis. Brain. 2008;131(Pt 10):2729&#x2010;2733.</Citation><ArticleIdList><ArticleId IdType="pubmed">18669498</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva&#x2010;Moraes MH, Bispo&#x2010;Torres AC, Barouh JL, et&#xa0;al. Suicidal behavior in individuals with amyotrophic lateral sclerosis: a systematic review. J Affect Disord. 2020;277:688&#x2010;696.</Citation><ArticleIdList><ArticleId IdType="pubmed">32911219</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowdon J, Choi NG. Undercounting of suicides: where suicide data lie hidden. Glob Public Health. 2020;15(12):1894&#x2010;1901.</Citation><ArticleIdList><ArticleId IdType="pubmed">32744898</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdmann A, Spoden C, Hirschberg I, Neitzke G. The wish to die and hastening death in amyotrophic lateral sclerosis: a scoping review. BMJ Support Palliat Care. 2021;11(3):271&#x2010;287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8380909</ArticleId><ArticleId IdType="pubmed">33397660</ArticleId></ArticleIdList></Reference><Reference><Citation>German RR, Fink AK, Heron M, et&#xa0;al. The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol. 2011;35(2):126&#x2010;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">20952269</ArticleId></ArticleIdList></Reference><Reference><Citation>Selikoff IJ, Seidman H. Use of death certificates in epidemiological studies, including occupational hazards: variations in discordance of different asbestos&#x2010;associated diseases on best evidence ascertainment. Am J Ind Med. 1992;22(4):481&#x2010;492.</Citation><ArticleIdList><ArticleId IdType="pubmed">1442783</ArticleId></ArticleIdList></Reference><Reference><Citation>Stickler DE, Royer JA, Hardin JW. Accuracy and usefulness of ICD&#x2010;10 death certificate coding for the identification of patients with ALS: results from the South Carolina ALS surveillance pilot project. Amyotroph Lateral Scler. 2012;13(1):69&#x2010;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">21929354</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil J, Funalot B, Verschueren A, et&#xa0;al. Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol. 2008;15(11):1245&#x2010;1251.</Citation><ArticleIdList><ArticleId IdType="pubmed">18973614</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>